Parity and risk of lung cancer in women

American Journal of Epidemiology

Volumn 171, Issue 5, 2010, Pages 557-563

  Paulus, Jessica K ^a   Asomaning, Kofi ^a   Kraft, Peter ^a   Johnson, Bruce E ^b   Lin, Xihong ^a   Christiani, David C ^a,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Lung neoplasms; Parity; Reproduction; Smoking; Women

Indexed keywords

CANCER; CHILDBEARING; GENDER ISSUE; HEALTH MONITORING; HEALTH RISK; SMOKING; SPATIOTEMPORAL ANALYSIS; WOMENS HEALTH;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SUSCEPTIBILITY; CIGARETTE SMOKING; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; GROUPS BY AGE; HUMAN; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CANCER; LUNG SQUAMOUS CELL CARCINOMA; MATERNAL AGE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NULLIPARA; PARITY; RACE;

AGED; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PARITY; PREGNANCY; RISK FACTORS;

BOSTON; MASSACHUSETTS; UNITED STATES;

EID: 77249093994     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp441     Document Type: Article

References (46)

1. Risch HA, Howe GR, Jain M, et al. Are female smokers at higher risk for lung cancer than male smokers? A case-control analysis by histologic type. Am J Epidemiol. 1993;138(5): 281-293.
2. Cheng YW, Hsieh LL, Lin PP, et al. Gender difference in DNA adduct levels among nonsmoking lung cancer patients. Environ Mol Mutagen. 2001;37(4):304-310.
3. Harris RE, Zang EA, Anderson JI, et al. Race and sex differences in lung cancer risk associated with cigarette smoking. Int J Epidemiol. 1993;22(4):592-599.
4. International Early Lung Cancer Action Program Investigators. Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA. 2006;296(2): 180-184.
5. Schwartz AG, Yang P, Swanson GM. Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol. 1996;144(6):554-562.
6. Osann KE, Anton-Culver H, Kurosaki T, et al. Sex differences in lung-cancer risk associated with cigarette smoking. Int J Cancer. 1993;54(1):44-48.
7. Kreuzer M, Boffetta P, Whitley E, et al. Gender differences in lung cancer risk by smoking: a multicentre case-control study in Germany and Italy. Br J Cancer. 2000;82(1):227-233. (Pubitemid 30008986)
8. Halpern MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J Natl Cancer Inst. 1993;85(6):457-464.
9. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Natl Cancer Inst. 2003;95(6): 470-478.
10. Freedman ND, Leitzmann MF, Hollenbeck AR, et al. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol. 2008;9(7):649-656.
11. Thun MJ, Lally CA, Flannery JT, et al. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst. 1997;89(21):1580-1586.
12. Russo J, Moral R, Balogh GA, et al. The protective role of pregnancy in breast cancer. Breast Cancer Res. 2005;7(3): 131-142.
13. La Vecchia C. Epidemiology of ovarian cancer: a summary review. Eur J Cancer Prev. 2001;10(2):125-129.
14. Seow A, Poh WT, Teh M, et al. Diet, reproductive factors and lung cancer risk among Chinese women in Singapore: evidence for a protective effect of soy in nonsmokers. Int J Cancer. 2002;97(3):365-371.
15. Kub́ik AK, Zatloukal P, Tomásek L, et al. Lung cancer risk among Czech women: a case-control study. Prev Med. 2002; 34(4):436-444.
16. Kreuzer M, Gerken M, Heinrich J, et al. Hormonal factors and risk of lung cancer among women? Int J Epidemiol. 2003; 32(2):263-271. (Pubitemid 36622273)
17. Brenner AV, Wang Z, Kleinerman RA, et al. Menstrual and reproductive factors and risk of lung cancer among Chinese women, Eastern Gansu Province, 1994-1998. J Epidemiol. 2003;13(1):22-28.
18. Liu Y, Inoue M, Sobue T, et al. Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study. Int J Cancer. 2005;117(4):662-666.
19. Kabat GC, Miller AB, Rohan TE. Reproductive and hormonal factors and risk of lung cancer in women: a prospective cohort study. Int J Cancer. 2007;120(10):2214-2220.
20. Gorlova OY, Zhang Y, Schabath MB, et al. Never smokers and lung cancer risk: a case-control study of epidemiological factors. Int J Cancer. 2006;118(7):1798-1804.
21. Schwartz AG, Wenzlaff AS, Prysak GM, et al. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J Clin Oncol. 2007; 25(36):5785-5792.
22. Garcia-Closas M, Kelsey KT, Wiencke JK, et al. A case-control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility (Massachusetts, United States). Cancer Causes Control. 1997;8(4): 544-553.
23. Miller DP, Neuberg D, de Vivo I, et al. Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms. Epidemiology. 2003;14(5):545-551.
24. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis. 1978;118(6):1-120.
25. Rotnitzky A, Robins J. Analysis of semi-parametric regression models with non-ignorable non-response. Stat Med. 1997; 16(1-3):81-102. (Pubitemid 27029290)
26. Kravdal O. Is the relationship between childbearing and cancer incidence due to biology or lifestyle? Examples of the importance of using data on men. Int J Epidemiol. 1995;24(3): 477-484.
27. Nichols HB, Trentham-Dietz A, Hampton JM, et al. From menarche to menopause: trends among US women born from 1912 to 1969. Am J Epidemiol. 2006;164(10):1003-1011.
28. Patrone C, Cassel TN, Pettersson K, et al. Regulation of postnatal lung development and homeostasis by estrogen receptor beta. Mol Cell Biol. 2003;23(23):8542-8552.
29. Stabile LP, Davis AL, Gubish CT, et al. Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogen. Cancer Res. 2002;62(7): 2141-2150.
30. Pietras RJ, Márquez DC, Chen HW, et al. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids. 2005;70(5-7):372-381.
31. Weinberg OK, Marquez-Garban DC, Fishbein MC, et al. Ar-omatase inhibitors in human lung cancer therapy. Cancer Res. 2005;65(24):11287-11291.
32. Kushner PJ, Agard DA, Greene GL, et al. Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol. 2000;74(5): 311-317.
33. Umayahara Y, Kawamori R, Watada H, et al. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem. 1994;269(23): 16433-16442.
34. Mollerup S, Jørgensen K, Berge G, et al. Expression of estrogen receptors alpha and beta in human lung tissue and cell lines. Lung Cancer. 2002;37(2):153-159.
35. Beattie CW, Hansen NW, Thomas PA. Steroid receptors in human lung cancer. Cancer Res. 1985;45(9):4206-4214.
36. Fasco MJ, Hurteau GJ, Spivack SD. Gender-dependent expression of alpha and beta estrogen receptors in human non-tumor and tumor lung tissue. Mol Cell Endocrinol. 2002; 188(1-2):125-140.
37. Kaiser U, Hofmann J, Schilli M, et al. Steroid-hormone receptors in cell lines and tumor biopsies of human lung cancer. Int J Cancer. 1996;67(3):357-364.
38. Schwartz AG, Prysak GM, Murphy V, et al. Nuclear estrogen receptor beta in lung cancer: expression and survival differences by sex. Clin Cancer Res. 2005;11(20):7280-7287.
39. Madigan MP, Troisi R, Potischman N, et al. Serum hormone levels in relation to reproductive and lifestyle factors in post-menopausal women (United States). Cancer Causes Control. 1998;9(2):199-207.
40. Key T, Appleby P, Barnes I, et al. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst. 2002;94(8):606-616.
41. Potischman N, Swanson CA, Siiteri P, et al. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst. 1996; 88(11):756-758.
42. Hankinson SE, Colditz GA, Hunter DJ, et al. Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States). Cancer Causes Control. 1995;6(3):217-224.
43. Dorgan JF, Reichman ME, Judd JT, et al. Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women. Cancer Epidemiol Bio-markers Prev. 1995;4(4):381-386.
44. Schabath MB, Wu X, Vassilopoulou-Sellin R, et al. Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res. 2004;10(1):113-123. (Pubitemid 38114169)
45. Schabath MB, Hernandez LM, Wu X, et al. Dietary phytoes-trogens and lung cancer risk. JAMA. 2005;294(12):1493-1504.
46. Schoen R. Insights from parity status life tables for the 20th century US. Soc Sci Res. 2006;35:29-39.